The current valuation score of Beigene Ltd is 5.85, ranking 370 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is 59.36, which is 933.87% below the recent high of 613.74 and 452.11% above the recent low of -209.02.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.